These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Biomarker-guided translation of brain imaging into disease pathway models. Younesi E; Hofmann-Apitius M Sci Rep; 2013 Nov; 3():3375. PubMed ID: 24287435 [TBL] [Abstract][Full Text] [Related]
43. A review of biomarkers of Alzheimer's disease in noninvasive samples. Hartmann S; Ledur Kist TB Biomark Med; 2018 Jun; 12(6):677-690. PubMed ID: 29896987 [TBL] [Abstract][Full Text] [Related]
44. Biomarkers for Alzheimer's disease: showing the way or leading us astray? Quinn JF J Alzheimers Dis; 2013; 33 Suppl 1(Suppl 1):S371-6. PubMed ID: 22766735 [TBL] [Abstract][Full Text] [Related]
45. Application of a multidisciplinary approach to Alzheimer's disease to develop novel drug targets by integrating biomarkers, imaging, genetic and molecular strategies. Lahiri DK Curr Alzheimer Res; 2011 Feb; 8(1):1-3. PubMed ID: 21265731 [No Abstract] [Full Text] [Related]
46. Welcome to the 11th Volume of Biomarkers in Medicine. Wilson H Biomark Med; 2017 Jan; 11(1):1-3. PubMed ID: 27967208 [No Abstract] [Full Text] [Related]
47. Alzheimer disease: Could tear proteins be biomarkers for Alzheimer disease? Wood H Nat Rev Neurol; 2016 Aug; 12(8):432. PubMed ID: 27389093 [No Abstract] [Full Text] [Related]
48. The definition and diagnosis of cold hypersensitivity in the hands and feet: Finding from the experts survey. Bae KH; Jeong YS; Go HY; Sun SH; Kim TH; Jung KY; Song YK; Ko SG; Choi YK; Park JH; Lee S; Lee Y; Jeon CY Integr Med Res; 2018 Mar; 7(1):61-67. PubMed ID: 29629292 [TBL] [Abstract][Full Text] [Related]
50. Biomarkers of Alzheimer's disease and mild cognitive impairment: a current perspective. Lewczuk P; Mroczko B; Fagan A; Kornhuber J Adv Med Sci; 2015 Mar; 60(1):76-82. PubMed ID: 25579841 [TBL] [Abstract][Full Text] [Related]
51. Trajectories of memory decline in preclinical Alzheimer's disease: results from the Australian Imaging, Biomarkers and Lifestyle Flagship Study of ageing. Pietrzak RH; Lim YY; Ames D; Harrington K; Restrepo C; Martins RN; Rembach A; Laws SM; Masters CL; Villemagne VL; Rowe CC; Maruff P; Neurobiol Aging; 2015 Mar; 36(3):1231-8. PubMed ID: 25585532 [TBL] [Abstract][Full Text] [Related]
52. Associations between biomarkers and age in the presenilin 1 E280A autosomal dominant Alzheimer disease kindred: a cross-sectional study. Fleisher AS; Chen K; Quiroz YT; Jakimovich LJ; Gutierrez Gomez M; Langois CM; Langbaum JB; Roontiva A; Thiyyagura P; Lee W; Ayutyanont N; Lopez L; Moreno S; Muñoz C; Tirado V; Acosta-Baena N; Fagan AM; Giraldo M; Garcia G; Huentelman MJ; Tariot PN; Lopera F; Reiman EM JAMA Neurol; 2015 Mar; 72(3):316-24. PubMed ID: 25580592 [TBL] [Abstract][Full Text] [Related]
53. Role of cerebrospinal fluid biomarkers in clinical trials for Alzheimer's disease modifying therapies. Kang JH; Ryoo NY; Shin DW; Trojanowski JQ; Shaw LM Korean J Physiol Pharmacol; 2014 Dec; 18(6):447-56. PubMed ID: 25598657 [TBL] [Abstract][Full Text] [Related]
54. A blood-based, 7-metabolite signature for the early diagnosis of Alzheimer's disease. Olazarán J; Gil-de-Gómez L; Rodríguez-Martín A; Valentí-Soler M; Frades-Payo B; Marín-Muñoz J; Antúnez C; Frank-García A; Acedo-Jiménez C; Morlán-Gracia L; Petidier-Torregrossa R; Guisasola MC; Bermejo-Pareja F; Sánchez-Ferro Á; Pérez-Martínez DA; Manzano-Palomo S; Farquhar R; Rábano A; Calero M J Alzheimers Dis; 2015; 45(4):1157-73. PubMed ID: 25649659 [TBL] [Abstract][Full Text] [Related]
55. Prediction of AD dementia by biomarkers following the NIA-AA and IWG diagnostic criteria in MCI patients from three European memory clinics. Prestia A; Caroli A; Wade SK; van der Flier WM; Ossenkoppele R; Van Berckel B; Barkhof F; Teunissen CE; Wall A; Carter SF; Schöll M; Choo IH; Nordberg A; Scheltens P; Frisoni GB Alzheimers Dement; 2015 Oct; 11(10):1191-201. PubMed ID: 25646957 [TBL] [Abstract][Full Text] [Related]
56. Comparison of two methods for the analysis of CSF Aβ and tau in the diagnosis of Alzheimer's disease. Faull M; Ching SY; Jarmolowicz AI; Beilby J; Panegyres PK Am J Neurodegener Dis; 2014; 3(3):143-51. PubMed ID: 25628965 [TBL] [Abstract][Full Text] [Related]
57. Diagnostic Values of Cerebrospinal Fluid T-Tau and Aβ₄₂ using Meso Scale Discovery Assays for Alzheimer's Disease. Pan C; Korff A; Galasko D; Ginghina C; Peskind E; Li G; Quinn J; Montine TJ; Cain K; Shi M; Zhang J J Alzheimers Dis; 2015; 45(3):709-19. PubMed ID: 25613100 [TBL] [Abstract][Full Text] [Related]
58. Brain amyloidosis ascertainment from cognitive, imaging, and peripheral blood protein measures. Apostolova LG; Hwang KS; Avila D; Elashoff D; Kohannim O; Teng E; Sokolow S; Jack CR; Jagust WJ; Shaw L; Trojanowski JQ; Weiner MW; Thompson PM; Neurology; 2015 Feb; 84(7):729-37. PubMed ID: 25609767 [TBL] [Abstract][Full Text] [Related]
59. A Candidate microRNA Profile for Early Diagnosis of Sporadic Alzheimer's Disease. Tsamou M; Kalligerou F; Ntanasi E; Scarmeas N; Skalicky S; Hackl M; Roggen EL J Alzheimers Dis Rep; 2023; 7(1):235-248. PubMed ID: 37090956 [TBL] [Abstract][Full Text] [Related]
60. Cerebrospinal Fluid Biomarkers for Early and Differential Alzheimer's Disease Diagnosis. Bjerke M; Engelborghs S J Alzheimers Dis; 2018; 62(3):1199-1209. PubMed ID: 29562530 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]